Prostate-specific membrane antigen (PSMA), a transmembrane glycoprotein, is frequently overexpressed in prostate cancer cells and is associated with early recurrence, resistance to castration therapy, and poor prognosis [2,3]. Here, FOLH1 is linked to prostate cancer.